M&A Deal Summary

Quest Diagnostics Acquires Celera

On March 18, 2011, Quest Diagnostics acquired internet software and services company Celera for 344M USD

Acquisition Highlights
  • This is Quest Diagnostics’ 1st transaction in the Internet Software and Services sector.
  • This is Quest Diagnostics’ 8th largest (disclosed) transaction.
  • This is Quest Diagnostics’ 8th transaction in the United States.
  • This is Quest Diagnostics’ 4th transaction in California.

M&A Deal Summary
Date 2011-03-18
Target Celera
Sector Internet Software and Services
Buyer(s) Quest Diagnostics
Deal Type Add-on Acquisition
Deal Value 344M USD

Target

Celera

Alameda, California, United States
Celera was founded in 1998 with the mission to sequence the human genome and provide clients with early access to the resulting data. Celera went on to build a successful database business, providing custom search tools and software that enabled dozens of pharmaceutical companies and hundreds of academic, government and biotech clients to use its findings in biological research.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Quest Diagnostics

Secaucus, New Jersey, United States
Category Company
Founded 1967
Sector Healthcare Services
Employees50,000
Revenue 9.3B USD (2023)
DESCRIPTION

Quest Diagnostics is a provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics was founded in 1967 and is based in Secaucus, New Jersey.

DEAL STATS #
Overall 9 of 38
Sector (Internet Software and Services) 1 of 1
Type (Add-on Acquisition) 8 of 26
State (California) 4 of 7
Country (United States) 8 of 35
Year (2011) 2 of 2
Size (of disclosed) 8 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-24 Athena Diagnostics

Marlborough, Massachusetts, United States

Athena Diagnostics, Inc. is a developer and provider of proprietary molecular diagnostic and immunodiagnostic tests and services.

Buy $740M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-01-03 S.E.D. Medical Laboratories

Albuquerque, New Mexico, United States

S.E.D. Medical Laboratories is a nationally recognized full-service medical and federally certified drugs-of-abuse testing laboratory with a staff of 450. S.E.D. operates from a modern 50,000 square-foot facility with state-of-the-art equipment and cutting-edge technology.

Buy -
Mergr

Product

Company

Legal